Polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: For 12 weeks, in addition to receiving basic treatment (from day 16 of the cycle for two weeks, 10 mg of medroxyprogesterone per night), she takes 6 mg of melatonin
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women in reproductive age (18-45) Women diagnosed with PCOS, based on Rotterdam criteria Who doesn't want to get pregnant for at least 3 months Most of patients are new cases If the patient has a medical history of taking medicines, should discontinue medications for at least 3 months before entering the study
Exclusion criteria
Exclusion criteria: Breastfeeding Wants to get pregnant Adrenal Hyperplasia Hyper Prolactinemia Mental Disorders Hypothyroidism Patients using hormonal medications or medications that cause weight loss and weight gain who's on a diet
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LH (luteinizing hormone) to FSH (follicle stimulating hormone) ratio. Timepoint: Measurement of blood LH and FSH levels at the beginning and end of the study. Method of measurement: Blood test.;BMI (body mass index). Timepoint: Measurement of height and weight at the beginning and end of the study. Method of measurement: Scale and stadiometer.;Quality of life. Timepoint: At the beginning and end of the study. Method of measurement: PCOSQ (polycystic ovarian syndrome quality of life questionnaire).;Hirsutism. Timepoint: At the beginning and end of the study. Method of measurement: Ferriman-Gallwey scoring scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh sadat Ayati
Tehran University of Medical Sciences
Outcome results
None listed